IRCT20130306012728N8招募中3 期
Prospective post-exposure hydroxycloroquine prophylaxis for Covid 19 (PROSCLOROCOV 19)
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit(—)
- 性别
- All
入选标准
- •All persons 18 years of age and older with a desire to participate in the study (resident of Tabriz), including medical staff or patient companions who have been in contact with an approved person with COVID19 over the past 4 days, and Corona test results using a nasopharyngeal swap sample (RT-PCR) and serum testing of Human SARS-Cov-2 IgG / IgM negative.
排除标准
- •Positive Corona test result
- •Allergy to Hydroxychloroquine
- •Retinal disease
- •History of epilepsy
- •Known deficiency of glucose-6 phosphate dehydrogenase
- •Chronic kidney disease known, stage 4 or 5 or under dialysis
- •Chronic liver failure
- •Weight <40 kg
- •Known porphyria
- •Current use of hydroxychloroquine
- •History of cardiovascular disease or medication (such as amiodarone, digoxin, etc.)
- •Recognized cancers
- •Types of autoimmune diseases
- •Pregnancy or lactation
- •Existence of fever and any respiratory illness and other infectious diseases when entering the study
研究者
相似试验
招募中
不适用
A study of hydroxychloroquine as post exposure prophylaxis for SARS-CoV-2 (HOPE trial)Certain infectious and parasitic diseasesKCT0004907Yonsei University Health System, Gangnam Severance Hospital2,486
终止
4 期
Hydroxychloroquine for Post-Exposure Prophylaxis of COVID-19 among naval personnel: a placebo-controlled, randomized, clinical trialPost-exposure prophylaxis for COVID-19SLCTR/2020/011Department of Medicine, Faculty of Medicine, University of Kelaniya
进行中(未招募)
1 期
PRE-EXPOSURE PROPHYLAXIS WITH HYDROXYCHLOROQUINE IN SANITARIES HIGHLY EXPOSED TO COVID-19. (COVIDNA)PRE-EXPOSURE PROPHYLAXIS WITH HYDROXYCHLOROQUINE IN SANITARIES HIGHLY EXPOSED TO COVID-19EUCTR2020-001697-30-ESAVARRABIOMED - FUNDACIÓN MIGUEL SERVET200
进行中(未招募)
1 期
Prevention of novel Coronavirus infection with hydroxychloroquineCOVID-19EUCTR2020-001565-37-ESISGlobal440
招募中
2 期
COVID-19 prophylaxis with hydroxychloroquine in Front-line Health and Allied-Health Care Workers: The COVID-SHIELD TrialCOVID-19 infectionInfection - Other infectious diseasesRespiratory - Other respiratory disorders / diseasesACTRN12620000501943Walter and Eliza Hall Institute of Medical Research650
